Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Ophthalmology

Are Retinal Spots (CHRPE) a Sign of FAP? What to Know

At a Glance

Retinal spots called CHRPE are usually harmless and cannot diagnose familial adenomatous polyposis. Multiple or bilateral spots, especially with unusual shapes or borders, may prompt an eye specialist visit and possible genetic or colon evaluation.

If your eye doctor noticed spots or freckles on your retina during a routine exam, you might be worried about what it means for your health. These spots are medically known as Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE). Having one of these spots does not automatically mean you have Familial Adenomatous Polyposis (FAP), and conversely, the absence of these spots does not guarantee you are free of FAP [1][2]. However, the number, shape, and location of these spots can provide important clues that may warrant further medical evaluation [1][3].

What is CHRPE?

CHRPE (pronounced “chirpy”) is a flat, pigmented spot (often called a “lesion” by doctors) on the retina, which is the light-sensitive tissue at the back of the eye. Most of the time, these spots are completely harmless and are discovered by chance during a routine eye exam [4]. Importantly, CHRPE spots are not eye cancer, usually do not cause any symptoms, and have little to no impact on your vision [4][5].

When Are Retinal Spots a Sign of FAP?

The connection between CHRPE and FAP depends heavily on the pattern of the spots found by an eye specialist:

  • Single Spots: A single, solitary CHRPE spot in one eye is relatively common in the general population and is typically benign and unrelated to FAP [1][6].
  • Multiple or Bilateral Spots: If you have multiple spots (often three or more) or spots in both eyes (bilateral), this pattern raises clinical suspicion and warrants professional assessment [2][7][3]. FAP-associated spots may also have irregular borders, oval shapes, or specific lighter areas within them [8][6].

While multiple or bilateral spots are a recognized clue for FAP, they are not a definitive diagnosis. You can have these spots without having an APC gene mutation (the genetic change responsible for most classic FAP) [2]. On the other hand, you can still have FAP-associated retinal spots even if you have no family history of colon polyps (growths in the colon lining) or colorectal cancer. This happens because the genetic mutation can occur de novo, meaning it is a new genetic change that happened in you and was not inherited from either parent [9][3].

If You Already Have FAP

If you have already been diagnosed with Familial Adenomatous Polyposis, the presence of CHRPE spots is simply an associated physical feature of the condition. Having these spots does not mean your FAP is more severe, nor does it indicate how many colon polyps you have. The spots do not replace or change your established gastrointestinal surveillance plan, and routine eye care should continue according to your ophthalmologist’s advice.

Next Steps to Consider

If an eye doctor identifies a suspicious pattern of CHRPE spots, this finding should prompt discussion with a specialized clinician, even if you feel perfectly healthy and have no gastrointestinal symptoms [3][9].

The typical evaluation pathway includes:

  • Confirmation by an Eye Specialist: An ophthalmologist or retinal specialist should carefully examine the spots to confirm their exact characteristics [1][10].
  • Genetic Counseling and Testing: A genetic counselor can help you decide if you need a multigene blood test to look for an APC mutation or other hereditary conditions. Keep in mind that a negative genetic test does not always rule out the need for physical screenings [7][3].
  • Gastrointestinal Evaluation: You may be referred to a gastroenterologist. Depending on your age, family history, and genetic test results, they may recommend a colonoscopy to examine your colon for polyps [9][11]. In some reported cases, patients without any gastrointestinal symptoms or family history were found to have extensive polyposis after their eye findings led to a colonoscopy [9][3].

While an eye exam cannot diagnose FAP on its own, it can be a vital piece of the puzzle in identifying your risk and guiding you toward proper care [7][2].

Common questions in this guide

Does having a CHRPE spot mean I have familial adenomatous polyposis?
No. A single CHRPE spot is fairly common and is usually harmless, while multiple or bilateral spots can be a clue that deserves further evaluation. CHRPE findings alone cannot diagnose FAP.
Which retinal spot patterns are more concerning for FAP?
Concern is greater when an eye specialist sees several spots, often three or more, in both eyes or with irregular borders, oval shapes, or lighter areas. These features are clues rather than proof of FAP and need professional interpretation.
Can I have FAP if I do not have CHRPE spots?
Yes. The absence of CHRPE does not rule out FAP, because not everyone with FAP has these retinal findings. Risk assessment may still depend on personal and family history, genetic testing, and colon evaluation.
What should I do if I have multiple CHRPE spots?
Ask an ophthalmologist or retinal specialist to confirm the number, location, and appearance of the spots. Depending on your age, family history, and findings, a genetic counselor may discuss APC or multigene testing, and a gastroenterologist may recommend colonoscopy.
Can FAP occur without a family history of colon polyps?
Yes. Some FAP-causing genetic changes occur de novo, meaning they arise for the first time in a person rather than being inherited from a parent. Therefore, a lack of family history does not by itself exclude FAP.
Do CHRPE spots show how severe FAP is?
No. In someone who already has FAP, CHRPE is an associated eye finding and does not show how severe the condition is or how many colon polyps are present. It also does not replace the person's recommended gastrointestinal surveillance.

Get notified when new evidence is published on Familial Adenomatous Polyposis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    Differentiating Sporadic and Familial Adenomatous Polyposis-Associated Congenital Hypertrophy of the Retinal Pigment Epithelium From Congenital Grouped Pigmentation: A Review of Morphologic, Histopathologic, and Multimodal Imaging.

    Manda AR, Machado K, Sivakumar V, et al.

    Cureus 2026; (18(7)):e113498 doi:10.7759/cureus.113498.

    PMID: 42524173
  2. 2

    Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) as a Screening Marker for Familial Adenomatous Polyposis (FAP): Systematic Literature Review and Screening Recommendations.

    Bonnet LA, Conway RM, Lim LA

    Clinical ophthalmology (Auckland, N.Z.) 2022; (16()):765-774 doi:10.2147/OPTH.S354761.

    PMID: 35321042
  3. 3

    RETINAL PIGMENT EPITHELIAL LESIONS ASSOCIATED WITH A SPORADIC CASE OF FAMILIAL ADENOMATOUS POLYPOSIS.

    Alsberge JB, Peng MY, Agarwal A, McDonald HR

    Retinal cases & brief reports 2022; (16(6)):759-761 doi:10.1097/ICB.0000000000001072.

    PMID: 33148946
  4. 4

    RETINAL PIGMENT EPITHELIAL TUMORS IN 948 EYES OF 926 PATIENTS.

    Shields CL, Attaseth T, Chou Y, et al.

    Retina (Philadelphia, Pa.) 2026; (46(7)):1160-1169 doi:10.1097/IAE.0000000000004827.

    PMID: 42308469
  5. 5

    Suspect asymptomatic lesions: Congenital hypertrophy of the Retinal Pigment Epithelium (CHRPE).

    Braga CS, Ricardo OMP, Cordeiro FM, et al.

    Romanian journal of ophthalmology 2021; (65(3)):275-278 doi:10.22336/rjo.2021.55.

    PMID: 35036651
  6. 6

    Retinal Pigment Epithelial Hamartomas in Familial Adenomatous Polyposis: New Insights Based on Multimodal Imaging of 233 Lesions.

    Kong CF, Go C, Wu SO, et al.

    Ophthalmology. Retina 2026; (10(6)):661-671 doi:10.1016/j.oret.2026.01.012.

    PMID: 41616853
  7. 7

    Diagnostic value of congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis: a systematic review.

    Asadi Khameneh E, Dadkhah R, Zangiabadian M, et al.

    International journal of retina and vitreous 2026; (12(1)).

    PMID: 42337665
  8. 8

    The link between colon cancer and congenital hypertrophy of the retinal pigment epithelium (CHRPE).

    Deibert B, Ferris L, Sanchez N, Weishaar P

    American journal of ophthalmology case reports 2019; (15()):100524 doi:10.1016/j.ajoc.2019.100524.

    PMID: 31384696
  9. 9

    A Closer Look: Familial Adenomatous Polyposis Suspected Through Ophthalmological Findings in an Adolescent.

    Freitas JD, Ferreira MR, Mota D, et al.

    Cureus 2025; (17(4)):e82857 doi:10.7759/cureus.82857.

    PMID: 40416288
  10. 10

    Advances in multimodal imaging for diagnosis of pigmented ocular fundus lesions.

    Verbeek S, Dalvin LA

    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2024; (59(4)):218-233 doi:10.1016/j.jcjo.2023.07.005.

    PMID: 37480939
  11. 11

    ACG Clinical Guideline: Diagnosis and Management of Adenomatous Colorectal Polyposis Syndromes.

    Mankaney G, Idos GE, Stoffel EM, et al.

    The American journal of gastroenterology 2026; (121(9)):2086-2120 doi:10.14309/ajg.0000000000004105.

    PMID: 42683623

This page is for informational purposes only and does not constitute medical advice. CHRPE cannot diagnose FAP; discuss your eye findings and need for genetic or gastrointestinal evaluation with a qualified clinician.